Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for Post-stroke Depression and Stroke Recurrence
NCT04776226Completed
- Sponsor
- Ege University
- Start
- Feb 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of citalopram in major depressive disorder (MDD), sponsored by Ege University. Primary endpoint: Stroke recurrence at 12 months. Started Feb 2017; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04776226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04776226.